Psychiatry & Neurology, Clinical Neurophysiology · Grand Rapids, MI
NPI
1417193087
Since 2009
Specialty
Psychiatry & Neurology, Clinical Neurophysiology
Code 2084N0600X
Group practices
2
Medicare group memberships
Hospitals
2
Hospital affiliations
245 Cherry St SE, Ste 104
Grand Rapids, MI, 49503
Phone (616) 685-8620
Groups this clinician bills Medicare through
Medicare paid, 2024
$27K
466 services
Medicare patients, 2024
195
Average age 64
Drug cost, 2024
$781K
2,801 prescriptions
Company payments, 2025
$282
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Mohammad J Poostizadeh was code 95720 (neurologic), 74 times for 38 patients. In total Mohammad J Poostizadeh billed 466 services in 26 codes, and Medicare paid $27K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2014-01-30.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 95720 Neurologic | Facility | 74 | 38 | $140.15 | $10K |
| 95870 Electrical Nerve Conductivity | Facility | 59 | 30 | $14.43 | $851 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 37 | 37 | $10.51 | $389 |
| 95938 Electrical Nerve Conductivity | Facility | 32 | 32 | $32.03 | $1,025 |
| 99214 Office E&M - Established | Facility | 26 | 26 | $51.23 | $1,332 |
| 95718 Neurologic | Facility | 24 | 23 | $80.11 | $1,923 |
| 99215 Office E&M - Established | Facility | 17 | 17 | $81.28 | $1,382 |
| 95812 Neurologic | Facility | 16 | 16 | $40.62 | $650 |
| 95939 Electrical Nerve Conductivity | Facility | 15 | 14 | $82.24 | $1,234 |
| 95819 Neurologic | Facility | 15 | 15 | $39.58 | $594 |
| 99213 Office E&M - Established | Facility | 13 | 12 | $42.56 | $553 |
By year: 2022 $18K for 262 services; 2023 $24K for 436 services; 2024 $27K for 466 services.
Medicare prescription drug claims, 2024
In 2024, the drug Mohammad J Poostizadeh prescribed most often to Medicare patients was Levetiracetam, with 499 prescriptions and refills. In total Mohammad J Poostizadeh wrote 2,801 Medicare prescriptions that cost $781K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levetiracetam Generic | 499 | 927 | 98 | $19K |
| Lacosamide Generic | 444 | 488 | 58 | $55K |
| Lamotrigine Generic | 256 | 534 | 49 | $6,517 |
| Clobazam Generic | 137 | 137 | 16 | $7,680 |
| Briviact Brivaracetam | 131 | 139 | 21 | $196K |
| Divalproex Sodium Generic | 120 | 143 | 18 | $7,934 |
| Zonisamide Generic | 115 | 213 | 25 | $4,682 |
| Divalproex Sodium Er Divalproex Sodium | 90 | 146 | 18 | $5,928 |
| Phenobarbital Generic | 87 | 91 | Under 11 | $4,676 |
| Topiramate Generic | 74 | 134 | 15 | $4,773 |
| Oxcarbazepine Generic | 62 | 149 | 18 | $5,234 |
| Xcopri Cenobamate | 61 | 62 | 11 | $66K |
| Nayzilam Midazolam | 60 | 60 | 21 | $43K |
| Clonazepam Generic | 59 | 63 | Under 11 | $630 |
| Carbamazepine Er Carbamazepine | 49 | 81 | Under 11 | $12K |
Brand drugs: 444 claims; generic drugs: 2,270 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Mohammad J Poostizadeh $282 ($282 in general payments such as food, travel and fees) from 2 companies. The largest payer was UCB, Inc. with $157.
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. UCB.BR | 2 | $157 |
| Neurelis, Inc. | 1 | $125 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.